Amicus Therapeutics

Amicus Therapeutics

World Rank (Jan-05-2024)
3,532
Market Cap (Jan-05-2024)
3.968 Billion USD
World Rank (Jul-30-2023)
3,630
Market Cap (Jul-30-2023)
3.862 Billion USD
World Rank (Jan-07-2022)
4,637
Market Cap (Jan-07-2022)
3.179 Billion USD
World Rank (Jan-01-2021)
2,536
Market Cap (Jan-01-2021)
6.017 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
FOLD
Market Cap (Mar-08-2026)
4.50
Employee Count
496
Employee Count as of Date
As on 2021
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
329 Million USD
Annual Operating Income in USD
-204 Million USD
Annual Net Income in USD
-236 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
724 Million USD
Total Liabilities in USD
601 Million USD
Total Equity in USD
123 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
HealthCare Products
Biotechnology
Company Website
AMICUS THERAPEUTICS INC
Wikipedia
Wikipedia
Yahoo
Yahoo @ Nasdaq
Company Profile

Amicus Therapeutics is a Biotechnology company. The headquarters is in USA.

Annual Results Summary

AMICUS THERAPEUTICS - Yearly Revenue and Net Income - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022329-204 (Loss)-236 (Loss)
Dec-2021305-199 (Loss)-250 (Loss)
Dec-2020260-243 (Loss)-276 (Loss)
Dec-2019182-300 (Loss)-356 (Loss)
Balance Sheet Summary

Total Assets as on Dec-2022 was 724 Million USD.

Total Liabilities as on Dec-2022 was 601 Million USD.

Total Equity as on Dec-2022 was 123 Million USD.

Founded Year
2002
IPO Year
2007
Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in USA
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share